1. Home
  2. ABEO vs PAMT Comparison

ABEO vs PAMT Comparison

Compare ABEO & PAMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABEO
  • PAMT
  • Stock Information
  • Founded
  • ABEO 1974
  • PAMT 1980
  • Country
  • ABEO United States
  • PAMT United States
  • Employees
  • ABEO N/A
  • PAMT N/A
  • Industry
  • ABEO Biotechnology: Pharmaceutical Preparations
  • PAMT Trucking Freight/Courier Services
  • Sector
  • ABEO Health Care
  • PAMT Industrials
  • Exchange
  • ABEO Nasdaq
  • PAMT Nasdaq
  • Market Cap
  • ABEO 256.9M
  • PAMT 272.9M
  • IPO Year
  • ABEO 1980
  • PAMT 1985
  • Fundamental
  • Price
  • ABEO $5.57
  • PAMT $13.47
  • Analyst Decision
  • ABEO Strong Buy
  • PAMT Hold
  • Analyst Count
  • ABEO 6
  • PAMT 1
  • Target Price
  • ABEO $18.00
  • PAMT $12.50
  • AVG Volume (30 Days)
  • ABEO 1.1M
  • PAMT 14.7K
  • Earning Date
  • ABEO 08-11-2025
  • PAMT 07-23-2025
  • Dividend Yield
  • ABEO N/A
  • PAMT N/A
  • EPS Growth
  • ABEO N/A
  • PAMT N/A
  • EPS
  • ABEO N/A
  • PAMT N/A
  • Revenue
  • ABEO N/A
  • PAMT $687,396,000.00
  • Revenue This Year
  • ABEO N/A
  • PAMT N/A
  • Revenue Next Year
  • ABEO $323.51
  • PAMT $9.03
  • P/E Ratio
  • ABEO N/A
  • PAMT N/A
  • Revenue Growth
  • ABEO N/A
  • PAMT N/A
  • 52 Week Low
  • ABEO $3.93
  • PAMT $11.01
  • 52 Week High
  • ABEO $7.32
  • PAMT $23.70
  • Technical
  • Relative Strength Index (RSI)
  • ABEO 37.51
  • PAMT N/A
  • Support Level
  • ABEO $5.66
  • PAMT N/A
  • Resistance Level
  • ABEO $6.24
  • PAMT N/A
  • Average True Range (ATR)
  • ABEO 0.26
  • PAMT 0.00
  • MACD
  • ABEO -0.08
  • PAMT 0.00
  • Stochastic Oscillator
  • ABEO 8.08
  • PAMT 0.00

About ABEO Abeona Therapeutics Inc.

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.

About PAMT PAMT CORP Common Stock

PAMT Corp is a holding company that is engaged in providing truckload dry van carriers transporting general commodities throughout the continental United States, as well as the Canadian provinces of Ontario and Quebec. It has one reportable segment being motor carrier.

Share on Social Networks: